No Data
No Data
Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
Viking Therapeutics (NASDAQ:VKTX) has outperformed the market over the past 5 years by 33.85% on an annualized basis producing an average annual return of 46.66%. Currently, Viking Therapeutics has a
Stifel Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $95
Stifel analyst Annabel Samimy maintains $Viking Therapeutics(VKTX.US)$ with a buy rating, and maintains the target price at $95.According to TipRanks data, the analyst has a success rate of 43.2% and
Stifel Nicolaus Reaffirms Their Buy Rating on Viking Therapeutics (VKTX)
Viking Therapeutics Stock Is Up by 154% Since January -- Can It Double Again in the Second Half of the Year?
3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics
Express News | Viking Therapeutics Inc : Morgan Stanley Initiates Coverage With Overweight Rating; Target Price $105
TracyD : Nice call